| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
0 |
| Employees |
16 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-27 |
| Cash Flow (TTM) (Millions $) |
0 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Kiromic Biopharma Inc is a biotechnology company that specializes in developing innovative cell therapies for the treatment of various types of cancer. The company utilizes its proprietary technology platform to engineer immune cells and develop targeted therapies that can effectively destroy cancer cells while minimizing damage to healthy tissues.
Kiromic Biopharma Inc focuses on advancing personalized medicine and precision oncology by tailoring treatments to individual patient's genetic makeup. They utilize genomic data and advanced analytics to identify specific cancer targets and develop therapies that can directly address those targets.
The company's pipeline includes a range of cancer immunotherapies, including CAR-T cell therapies, T-cell receptor therapies, and immune checkpoint modulators. They are actively involved in preclinical and clinical trials to evaluate the safety and efficacy of their therapies.
Kiromic Biopharma Inc aims to provide patients with novel treatment options that have the potential to enhance survival rates and improve overall outcomes in cancer treatment. They collaborate with academic institutions, research organizations, and clinical partners to further advance their therapeutic approaches and bring their innovative treatments to the market.
Company Address: 7707 Fannin Street, Suite 200 Houston 77054 TX
Company Phone Number: 968-4888 Stock Exchange / Ticker: KRBP
|
%
